PT824356E - Composicoes farmaceuticas para o tratamento da dependencia do alcool - Google Patents
Composicoes farmaceuticas para o tratamento da dependencia do alcoolInfo
- Publication number
- PT824356E PT824356E PT96919706T PT96919706T PT824356E PT 824356 E PT824356 E PT 824356E PT 96919706 T PT96919706 T PT 96919706T PT 96919706 T PT96919706 T PT 96919706T PT 824356 E PT824356 E PT 824356E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- treatment
- pharmaceutical compositions
- date nov
- alcohol dependence
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 2
- 201000007930 alcohol dependence Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- FEFAIBOZOKSLJR-UHFFFAOYSA-N Miltirone Chemical compound C1CCC(C)(C)C=2C1=C1C(=O)C(=O)C(C(C)C)=CC1=CC=2 FEFAIBOZOKSLJR-UHFFFAOYSA-N 0.000 abstract 2
- 206010013663 drug dependence Diseases 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 208000011117 substance-related disease Diseases 0.000 abstract 2
- 241001072909 Salvia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 abstract 1
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 abstract 1
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI950958A IT1274481B (it) | 1995-05-12 | 1995-05-12 | Composizioni farmaceutiche per il trattamento della alcol-dipendenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT824356E true PT824356E (pt) | 2002-12-31 |
Family
ID=11371582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96919706T PT824356E (pt) | 1995-05-12 | 1996-05-08 | Composicoes farmaceuticas para o tratamento da dependencia do alcool |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5904923A (pt) |
| EP (1) | EP0824356B1 (pt) |
| JP (1) | JP2955370B2 (pt) |
| KR (1) | KR100290029B1 (pt) |
| CN (1) | CN1066336C (pt) |
| AT (1) | ATE221384T1 (pt) |
| AU (1) | AU695010B2 (pt) |
| CA (1) | CA2220703C (pt) |
| DE (1) | DE69622704T2 (pt) |
| DK (1) | DK0824356T3 (pt) |
| ES (1) | ES2180783T3 (pt) |
| IT (1) | IT1274481B (pt) |
| NO (1) | NO318659B1 (pt) |
| PT (1) | PT824356E (pt) |
| RU (1) | RU2153345C2 (pt) |
| WO (1) | WO1996035441A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2243005T3 (es) | 1997-07-30 | 2005-11-16 | Indena S.P.A. | Extracto de soja, proceso para su preparacion y composicion farmaceutica. |
| US5968746A (en) | 1997-11-26 | 1999-10-19 | Schneider; David R. | Method and apparatus for preserving human saliva for testing |
| AU2001286409A1 (en) * | 2000-08-03 | 2002-02-18 | Hong Kong University Of Science And Technology | N-methyl-d-aspartate receptor antagonists |
| CN1304723A (zh) * | 2001-01-16 | 2001-07-25 | 中山大学 | 含二氢呋喃环结构的丹参酮类化合物用于治疗肝性脑病的药物 |
| US6852342B2 (en) | 2002-03-26 | 2005-02-08 | Avoca, Inc. | Compounds for altering food intake in humans |
| WO2004058245A1 (fr) * | 2002-12-31 | 2004-07-15 | Zhongshan Univertsity | Utilisation de la tanshinone iia dans la prophylaxie ou le traitement de l'atherosclerose |
| US9827314B2 (en) * | 2003-12-08 | 2017-11-28 | Mars, Incorporated | Edible compositions which are adapted for use by a companion animal |
| CA2604887A1 (en) * | 2005-04-07 | 2006-10-19 | Hythiam, Inc. | Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence |
| GB201312205D0 (en) * | 2013-07-08 | 2013-08-21 | Univ Leuven Kath | Anticonvulsant activity of dan shen extracting compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1239281B (it) * | 1989-10-27 | 1993-10-19 | Indena Spa | Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica |
| RU2011382C1 (ru) * | 1989-11-20 | 1994-04-30 | Научно-исследовательский институт фармакологии Томского научного центра РАН | Антиалкогольное средство |
| US5204369A (en) * | 1991-07-01 | 1993-04-20 | The Endowment For Research In Human Biology | Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
-
1995
- 1995-05-12 IT ITMI950958A patent/IT1274481B/it active IP Right Grant
-
1996
- 1996-05-08 AT AT96919706T patent/ATE221384T1/de active
- 1996-05-08 DE DE69622704T patent/DE69622704T2/de not_active Expired - Lifetime
- 1996-05-08 RU RU97120507/14A patent/RU2153345C2/ru not_active IP Right Cessation
- 1996-05-08 CN CN96193877A patent/CN1066336C/zh not_active Expired - Fee Related
- 1996-05-08 ES ES96919706T patent/ES2180783T3/es not_active Expired - Lifetime
- 1996-05-08 EP EP96919706A patent/EP0824356B1/en not_active Expired - Lifetime
- 1996-05-08 CA CA002220703A patent/CA2220703C/en not_active Expired - Fee Related
- 1996-05-08 KR KR1019970708033A patent/KR100290029B1/ko not_active Expired - Fee Related
- 1996-05-08 DK DK96919706T patent/DK0824356T3/da active
- 1996-05-08 WO PCT/EP1996/001916 patent/WO1996035441A1/en not_active Ceased
- 1996-05-08 US US08/945,986 patent/US5904923A/en not_active Expired - Lifetime
- 1996-05-08 AU AU58153/96A patent/AU695010B2/en not_active Ceased
- 1996-05-08 JP JP8533745A patent/JP2955370B2/ja not_active Expired - Fee Related
- 1996-05-08 PT PT96919706T patent/PT824356E/pt unknown
-
1997
- 1997-11-11 NO NO19975177A patent/NO318659B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI950958A0 (it) | 1995-05-12 |
| NO975177D0 (no) | 1997-11-11 |
| US5904923A (en) | 1999-05-18 |
| WO1996035441A1 (en) | 1996-11-14 |
| DE69622704T2 (de) | 2003-04-03 |
| EP0824356B1 (en) | 2002-07-31 |
| ITMI950958A1 (it) | 1996-11-12 |
| RU2153345C2 (ru) | 2000-07-27 |
| KR19990014692A (ko) | 1999-02-25 |
| JP2955370B2 (ja) | 1999-10-04 |
| DK0824356T3 (da) | 2002-11-25 |
| JPH10512583A (ja) | 1998-12-02 |
| EP0824356A1 (en) | 1998-02-25 |
| ATE221384T1 (de) | 2002-08-15 |
| NO975177L (no) | 1997-11-11 |
| IT1274481B (it) | 1997-07-17 |
| NO318659B1 (no) | 2005-04-25 |
| KR100290029B1 (ko) | 2001-05-15 |
| CA2220703A1 (en) | 1996-11-14 |
| ES2180783T3 (es) | 2003-02-16 |
| AU695010B2 (en) | 1998-08-06 |
| CA2220703C (en) | 2001-07-24 |
| HK1009096A1 (en) | 1999-05-28 |
| CN1184429A (zh) | 1998-06-10 |
| DE69622704D1 (de) | 2002-09-05 |
| CN1066336C (zh) | 2001-05-30 |
| AU5815396A (en) | 1996-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200101481T2 (tr) | Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi. | |
| BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
| ATE180166T1 (de) | Pflanzliche aktive wirkstoffe enthaltende pharmazeutische zubereitungen,verfahren zur herstellung und verwendung zu medizinischen und veterinaeren zwecken | |
| KR910007539A (ko) | 인체 지방축적물 치료용 조성물 | |
| NZ297879A (en) | Ondansetron and polyhydric alcohol (a sweetener) in a liquid acidic oral composition form | |
| BR9508373A (pt) | Preparação farmacêutica uso da preparação farmacêutica e processos para preparar a preparação farmacêutica e para aliviar dor | |
| PT824356E (pt) | Composicoes farmaceuticas para o tratamento da dependencia do alcool | |
| ATE318610T1 (de) | Orale zusammensetzungen zur behandlung von kopfhauterkrankungen | |
| IT1282736B1 (it) | Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative | |
| DE60143078D1 (de) | Pax2 zur behandlung von nierenkrankheiten | |
| AR004326A1 (es) | Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista. | |
| DE69419854D1 (de) | Arzneimittelzusammensetzung zur Prophylaxe und Behandlung vorzeitigen Samenergusses | |
| FI962550A0 (fi) | Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa | |
| AR008506A1 (es) | Composicion farmaceutica. | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| DE60030786D1 (de) | Murraya koenigii-extrakte zur behandlung von asthma | |
| PT825859E (pt) | Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool | |
| ES2189923T3 (es) | Uso de un extracto que contiene flavonoides de la planta euphorbia prostata en la preparacion de un medicamento para el tratamiento de desordenes anorectales y del colon. | |
| ATE380555T1 (de) | Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng | |
| BR0012140A (pt) | Composição para o alìvio da dor em um corpo humano, e, método para o tratamento da dor em um corpo humano | |
| Hemangi et al. | A brief review on Ginkgo biloba L.(maidenhair tree) a rare multipurpose medicinal plant | |
| UA36346A (uk) | Лікувальний збір для стимулювання статевої гормональної функції /варіанти/ та спосіб лікування первинної аменореї у дівчат-підлітків | |
| RU96108005A (ru) | Лечебно-профилактическая пищевая композиция "женсолар", обладающая алкопротекторным действием | |
| BR0102184A (pt) | Uso de produto compreendendo extrato de catuama como agente antidepressivo e nos distúrbios da ansiedade, composição farmacêutica compreendendo tal produto para tratamento ou prevenção da depressão e/ou distúrbios da ansiedade, método para tratamento ou prevenção da depressão e/ou distúrbios da ansiedade usando o referido produto e uso do referido produto para produção de uma composição farmacêutica para tratamento ou prevenção da depressão e/ou distúrbios da ansiedade |